ViroGates AS (OCSE:VIRO) Beginning Cash Position : kr12.21 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is ViroGates AS Beginning Cash Position?

ViroGates AS's Beginning Cash Position for the quarter that ended in Mar. 2025 was kr12.21 Mil.

ViroGates AS's quarterly Beginning Cash Position increased from Sep. 2024 (kr8.74 Mil) to Dec. 2024 (kr15.56 Mil) but then declined from Dec. 2024 (kr15.56 Mil) to Mar. 2025 (kr12.21 Mil).

ViroGates AS's annual Beginning Cash Position declined from Dec. 2022 (kr14.86 Mil) to Dec. 2023 (kr9.88 Mil) but then increased from Dec. 2023 (kr9.88 Mil) to Dec. 2024 (kr16.03 Mil).

ViroGates AS Beginning Cash Position Historical Data

The historical data trend for ViroGates AS's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViroGates AS Beginning Cash Position Chart

ViroGates AS Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

41.41

33.52

14.86

9.88

16.03

ViroGates AS Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Beginning Cash Position	Get a 7-Day Free Trial															16.03	12.23	8.74	15.56	12.21

ViroGates AS Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

ViroGates AS Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of ViroGates AS's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

ViroGates AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ViroGates AS (OCSE:VIRO) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

EP2:Germany

Address

Banevaenget 13, Birkerod, DNK, DK-3460

Website

https://www.virogates.com

ViroGates AS is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.

ViroGates AS Headlines

No Headlines